Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |
Company developing lysin based therapeutics for treating infectious diseases caused by bacteria
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |